OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/11/2025
Back to search
Official data from USPTO
NECSTRIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
12/12/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
05/06/2024
Registration date
02/04/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/04/2025
Last transaction
12/12/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
DE
Examiner
JANSON,ANDREW KYLE
Law office
L50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Boehringer Ingelheim International GmbH
Representatives
Boehringer Ingelheim International GmbH
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular systemmusculoskeletal systemcentral nervous systemperipheral nervous systemgenitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disordersdamaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparationscell based immune therapeutics for treatment of cancerfor treatment of immunological diseasestreatment of infectious diseases.
Publications
History of USPTO decisions and trademark events.
13 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/26/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/26/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/06/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
02/04/2025
PUBO
PUBLISHED FOR OPPOSITION
12/17/2024
NPUB
NOTICE OF PUBLICATION
12/11/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/21/2024
DOCK
ASSIGNED TO EXAMINER
11/19/2024
MAFR
APPLICATION FILING RECEIPT MAILED
07/24/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/24/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/23/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/27/2024
Continuous trademark protection
Get notified about every new filing that threatens NECSTRIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.